Fractalkine (FKN) has been implicated in modulating angiogenesis and vascular inflammation, but the underlying mechanism has not been elucidated. We here investigated the molecular mechanism by which FKN regulates angiogenesis. We found that recombinant FKN increased 
ዊ hematoxylin and eosin. Non-migrating cells on the upper surface of the filter were removed by wiping with a cotton swab, and chemotaxis was observed by using an inverted phase contrast microscope. Images were captured with a video graphic system. Chemotaxis was quantified by counting the cells that migrated to the lower side of the filter at low-power fields (x100).
Tube formation assay
The formation of tube-like structures by HUVECs on growth factor-reduced Matrigel was performed as previously described (25). Twenty-four well culture plates were coated with Matrigel according to the manufacturer's instructions. HUVECs were incubated in M199
containing 1% FBS for 6 h, and plated onto the layer of Matrigel at a density of 2.0 x 10 5 cells/well, followed by the addition of FKN or VEGF with or without inhibitors. Matrigel cultures were incubated at 37 o C for 20 h. Tube formation was observed using an inverted phase contrast microscope. Images were captured with a video graphic system. The degree of tube formation was quantified by measuring the length of tubes in 5 randomly chosen low-power fields (x100) from each well using the Image-Pro Plus v4.5 (Media Cybernetics, San Diego, CA, USA).
ዊ collagen was applied to thermanox disks and polymerized at room temperature. The discs were loaded onto the CAM of 10-day-old embryos. After 70 ± 4 h incubation at 37°C, the area around the loaded disk was photographed with a digital camera and the number of newly formed vessels was counted by two observers in a double-blinded manner. Assays for each test sample were carried out using 18-20 eggs.
Intravital fluorescence microscopy
Male BALB/c mice (6-8 wk old) were obtained from Daehan Biolink and maintained at the specific pathogen-free housing facility at the School of Medicine, University of Kangwon National University (Chunchon, Korea). All procedures performed on these animals were in accordance with the guidelines of the University Animal Care and Use Committee. Mice were anesthetized by inhalation of isoflurane 1.5% and a mixture of O 2 /N 2 O, using a vaporizer (Surgivet, Waukesha, WI) and abdominal wall windows were implanted. A titanium circular mount with 8 holes on the edge (19 mm outer diameter, 14 mm inner diameter, and 0.7 mm thick) was inserted between the skin and abdominal wall. Growth-factor reduced Matrigel containing VEGF (100 ng/mouse) or FKN (100 ng/mouse) was put into the windows inner space and a circular glass coverslip was placed on top and fixed by a snap ring. After 4 days, animals were anesthetized and received an intravenous injection of 50 µl of 25 mg/ml fluorescein isothiocyanate-labeled dextran (MW 250,000) via tail vein. Mice were then placed on a Zeiss Axiovert 200M microscope. The epi-illumination microscopy setup included a 100-W mercury lamp and filter set for blue light (440-475 nm, excitation wavelength; 530-550 nm, emission wavelength). Fluorescence images were recorded in five random locations of each window by a electron-multiplying CCD camera (Photon Max 512; Princeton Instruments, Trenton, NJ) and digitized for subsequent off-line analysis using the MetaMorph program ዊዊ (Universal Imaging Corp., Downingtown, PA). The assay was scored from 0 (least positive) to 5 (most positive) in a double-blinded manner.
Nitric oxide (NO) measurement
The NO level in HUVECs was measured in situ by using DAF-FM diacetate (Molecular Probes Inc.). Briefly, 7 h after FKN treatment, cells were washed twice with serum-free medium and then incubated with 5 µM DAF-FM diacetate for 1 h at 37 o C. After the excess probe was removed, cells were incubated for an additional 20 min to allow for complete de-esterification of the intracellular DAF-FM diacetate to the non-permeable and non-fluorescent DAF-FM, which is converted to the highly fluorescent triazol form in the presence of NO and oxygen. The fluorescence images were captured from at least 10 randomly selected cells per dish using a confocal laser microscope. The relative levels of intracellular NO were determined from fluorescence intensity of DAF-FM.
Statistical analysis
The data are presented as means ± SE and statistical comparisons between groups were performed using one-way ANOVA followed by the Student's t test. P<0.05 was considered statistically significant.
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RESULTS
FKN stimulates ex vivo and in vivo angiogenesis
Angiogenesis is a complex biological process, which requires the precise coordination of multiple and various steps such as endothelial cell proliferation, migration, and tube formation.
As shown in previous studies (5, 44) , FKN treatment significantly increased endothelial cell proliferation in dose-and time-dependent manners compared with the well-known angiogenic factor VEGF ( Fig. 1A and B) . When endothelial cell numbers were counted following FKN treatment, cell proliferation was also significantly increased in a concentration-dependent manner (data not shown). We next examined whether FKN would induce endothelial cell migration using Transwell plates. Treatment of HUVECs with FKN for 4 h significantly increased migration in a concentration-dependent manner up to 20 ng/ml, which is relatively comparable to that of VEGF treatment (Fig. 1C) . Furthermore, FKN treatment resulted in a dose-dependent increase in in vitro tube-like structure formation (Fig. 1, D) . The angiogenic effects of FKN did not further increase at higher concentration than 20 ng/ml, while the angiogenic effects of VEGF reached maximum at 40 ng/ml (Fig. 1A , C, and D). When treated with 10 µg FKN, the in vitro proliferation, migration, and tube formation reached to almost maximum with 2.3-, 2.2-, and 3.0-fold increases compared with control, and these angiogenic activities induced by 10 ng/ml of FKN were comparable to those of VEGF (10 ng/ml). We further confirmed the ex vivo and in vivo angiogenic activity of FKN. Treatment with FKN resulted in about a 3-fold increase in vessel sprouting in the cut edge of rat aortic rings compared with control ( Fig. 2A) . The addition of FKN stimulated a significant number of newly formed blood vessels compared with that of control, as measured by the chick CAM assay (Fig.   2B ). Angiogenic activity of FKN was also observed in a mouse model by intravital microscopy (Fig. 2C) . All of these angiogenic activities observed with FKN were comparable to those of 
FKN increases PI3K/Akt-dependent NO generation
The chemokine for endothelial progenitor cells, CXCL12, and VEGF activate Akt- VEGF-neutralizing antibody reduced VEGF (10 ng/ml)-mediated phosphorylation of ERK, Akt, and eNOS, but did not affect FKN-mediated phosphorylation (Fig. 7A ). In addition, the combined treatment with FNK (20 ng/ml) and VEGF (40 ng/ml), which resulted in maximum ዊዊ angiogenic activity, showed a partial increase in the phosphorylated activation of ERK, Akt, and eNOS, suggesting that both angiogenic factors utilize the same or overlapping signaling mechanism. Furthermore, this neutralizing antibody significantly reduced VEGF-induced HUVEC proliferation, but did not alter the proliferative effect of FKN (Fig. 7B) . We also observed that FKN-induced HUVEC migration and tube formation were not affected by the VEGF-neutralizing antibody (data not shown). We next examined whether FKN regulated VEGF expression, as assessed by RT-PCR analysis. As previously reported, TNF-markedly increased the VEGF transcript in HUVECs after 8 h treatment, whereas FKN did not increase the levels of VEGF mRNA ( FKN stimulated HUVEC proliferation, migration and tube-like structure formation in vitro in a concentration-dependent manner from concentrations as low as 1 ng/ml to 10 ng/ml, where it exhibited similar activity to VEGF a well-known angiogenic factor, at a concentration of 10 ng/ml (Fig. 1) . FKN also exerted similar angiogenic activity ex vivo and in vivo to that of VEGF at the same concentration (Fig. 2) . However, treatment of HUVECs with a higher concentration (20 ng/ml) of FKN showed no further significant increase in angiogenic activity, while VEGF elevated endothelial cell proliferation and migration in a dose-dependent manner and reached a maximum at 40 ng/ml (Fig. 1 
